|
CCNB2 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.63191682389652E-12 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.994820E-04 |
| Normal-vs-Stage2 |
3.558400E-02 |
| Normal-vs-Stage3 |
1.96530999999611E-05 |
| Normal-vs-Stage4 |
5.998300E-03 |
| Stage1-vs-Stage2 |
6.230600E-01 |
| Stage1-vs-Stage3 |
1.164290E-03 |
| Stage1-vs-Stage4 |
1.254410E-02 |
| Stage2-vs-Stage3 |
5.177600E-02 |
| Stage2-vs-Stage4 |
6.543600E-02 |
| Stage3-vs-Stage4 |
7.608800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.2408999362541E-10 |
| Normal-vs-AfricanAmerican |
4.00139999999771E-05 |
| Normal-vs-Asian |
5.550500E-02 |
| Caucasian-vs-AfricanAmerican |
8.573400E-01 |
| Caucasian-vs-Asian |
1.584020E-01 |
| AfricanAmerican-vs-Asian |
7.341800E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.62492241884138E-12 |
| Normal-vs-Female |
4.28599999999779E-05 |
| Male-vs-Female |
2.265600E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.586440E-04 |
| Normal-vs-Extreme_Weight |
7.94890042676855E-10 |
| Normal-vs-Obese |
1.44369999954819E-07 |
| Normal-vs-Extreme_Obese |
5.980400E-02 |
| Normal_Weight-vs-Extreme_Weight |
7.748100E-02 |
| Normal_Weight-vs-Obese |
7.929800E-01 |
| Normal_Weight-vs-Extreme_Obese |
2.060900E-03 |
| Extreme_Weight-vs-Obese |
3.403800E-02 |
| Extreme_Weight-vs-Extreme_Obese |
2.182600E-03 |
| Obese-vs-Extreme_Obese |
7.87970000000193E-05 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.401600E-03 |
| Normal-vs-Age(41-60Yrs) |
4.85990137022441E-11 |
| Normal-vs-Age(61-80Yrs) |
5.77659999999591E-05 |
| Normal-vs-Age(81-100Yrs) |
4.178700E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.894100E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.576300E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.646400E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.944800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.835820E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.563800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
2.43138842392909E-14 |
| Normal-VS-Type2 PRCC |
2.83240000009677E-07 |
| Normal-VS-KIRP CIMP |
3.627300E-04 |
| Normal-VS-Unclassified PRCC |
4.800500E-04 |
| Type1 PRCC-VS-Type2 PRCC |
7.301200E-03 |
| Type1 PRCC-VS-KIRP CIMP |
9.582300E-04 |
| Type1 PRCC-VS-Unclassified PRCC |
1.309030E-01 |
| Type2 PRCC-VS-KIRP CIMP |
7.59980000042404E-07 |
| Type2 PRCC-VS-Unclassified PRCC |
5.462800E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
1.995830E-03 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.45019999999263E-05 |
| Normal-vs-N1 |
9.83329999981741E-07 |
| Normal-vs-N2 |
6.828200E-02 |
| N0-vs-N1 |
2.573700E-04 |
| N0-vs-N2 |
1.039450E-01 |
| N1-vs-N2 |
4.340800E-01 |
|
|
